Biovian will attend BIO-Europe Spring 2015 from 9-11 March 2015 in Paris, France.
The company’s CEO, Dr Knut Ringbom will be available for in-depth discussions with delegates at the partnering offered at the conference.
About Biovian
Biovian provides GMP contract manufacturing of biopharmaceuticals covering services from early development to finished vials. The company’s 2300m² facilities are EMA and FDA certified for cGMP production of investigational and commercial products.
Biovian GMP services include:
- Microbial fermentation
- Mammalian cell culture
- Viral vector production
- Protein purification
- Formulation
- Aseptic fill and finish
- Analytical quality control services
- Stability studies
- Master cell banking
- Drug product labelling, packaging, storage and QP release
Biovian development services include cell line, process and analytical development.